Paul Foster

Part of Sanofi, Genzyme Ltd. is a healthcare organization based in Haverhill, UK. Genzyme Ltd. is involved in research and development, transforming scientific innovation into healthcare solutions for people nationwide and across the globe. The British company witnesses the miracles of science when hard work results in new, cutting-edge medicines, services, and devices. Founded in 1981, the company works with the NHS and the pharmaceutical industry to deliver patient-centered initiatives, including joint working projects.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.